Epic Medical Research Joins hyperCORE International to Enhance Global Clinical Trials

Epic Medical Research has officially joined hyperCORE International's global partner site network, a strategic move that promises to significantly enhance the efficiency and scope of clinical trials across the globe. Operating from 12 state-of-the-art locations in Dallas, Texas, Epic Medical Research specializes in a wide range of therapeutic areas, including metabolic disorders, fatty liver disease, and neurological conditions. This partnership is set to leverage the strengths of both organizations to advance clinical research and improve patient outcomes.

Dr. Haresh Boghara, President & Principal Investigator at Epic Medical Research, shared his enthusiasm for the collaboration, emphasizing the shared vision between Epic and hyperCORE International for pushing the boundaries of clinical research. The alliance is anticipated to grant Epic access to enhanced resources and a more extensive platform for delivering cutting-edge clinical trial solutions. Nicholas Focil, President of hyperCORE International, praised Epic Medical Research for its comprehensive therapeutic expertise and operational capabilities, highlighting the synergy with hyperCORE's objective to improve trial performance across its network.

Founded in 2019, hyperCORE International is a consortium of premier clinical research site organizations, boasting over 80 active trial sites in five countries. The network's collaborative model, which prioritizes efficiency, standardization, and excellence, has successfully completed more than 7,000 studies with over 140,000 participants. The inclusion of Epic Medical Research into hyperCORE's network is a testament to hyperCORE's dedication to fostering clinical research advancements through strategic collaborations. For further details on hyperCORE International and its endeavors, visit https://www.hypercoreinternational.com.